This project demonstrates practical application of CNNs in medical imaging, including proper evaluation metrics, model interpretability, and ethical considerations.

#Ethical Considerations and Limitations

important Disclaimers

⚠️  Critical Limitations:

1. Population Bias: 
   - Dataset is from pediatric patients in China; it may not generalize to adults, different ethnicities, or populations.
  

2. Class Imbalance:
   - Dataset heavily skewed toward pneumonia cases therefore, model may have different performance in clinical settings.

3. Image Quality:
   - Training data quality may differ from clinical equipment, different X-ray machines, exposures, positioning can affect results.

4. Limited Pathology:
   - Only trained on Normal vs Pneumonia. Cannot detect other lung conditions (cancer, TB, COVID-19, etc.). Therefore, this model may misclassify other abnormalities


# Deployment Considerations

Before Clinical Use:

1. Regulatory Approval:
   - Requires extensive validation on diverse populations. Also, Regular audits and monitoring required

2. Integration with Workflow:
   - AI is a decision support tool, not a replacement for radiologists. All predictions must be reviewed by qualified clinicians.

3. Bias and Fairness:
   - Test performance across different demographics. Monitor for systematic errors in specific populations. Ensure equal performance across age, gender, ethnicity.

4. Explainability:
   - Clinicians must understand model decisions (Grad-CAM helps).

# False Negative Concerns

**False negatives (missing pneumonia) have serious consequences:**
- Delayed treatment can worsen patient outcomes
- Particularly dangerous for vulnerable populations (children, elderly, immunocompromised)
- Model should err on the side of caution (prioritize sensitivity over specificity)
- Consider lowering classification threshold for pneumonia detection

---

*DISCLAIMER: This model is for educational purposes only and should NOT be used for actual medical diagnosis. Real-world medical AI systems require extensive validation, regulatory approval, and integration into clinical workflows with appropriate oversight.
